With a number of Critical Limb Ischemia (CLI) trials being initiated, the real race at this point will be to enroll sites and patients for these trials. Read more…
The FDA has approved Harvest Technologies’ (HT) sponsored 210 patient IDE clinical trial to be conducted at 25 sites Read more…
Another potential competitor of ASTM, Harvest Technologies and PSTI emerges, initiating CLI trials. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.